
Pharma
What Eli Lilly’s psychedelic investment could mean for the emerging field
Analysis of clinical development, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.

Pharma
What Eli Lilly’s psychedelic investment could mean for the emerging field

Pharma
Novo and Lilly race to bring next-generation GLP-1s to market

Pharma
Johnson & Johnson to buy Proteologix for $850m
Pharma
How AstraZeneca is making up for declining Covid-19 sales

Pharma
AstraZeneca has big R&D goals to mitigate future declines in Covid-related sales